Comment on: Methotrexate pharmacogenomics in rheumatoid arthritis: Introducing false positive report probability

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1619-1620
Number of pages2
JournalRheumatology
Volume48
Issue number12
DOIs
Publication statusPublished - 2009

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Rheumatology

Cite this

Comment on : Methotrexate pharmacogenomics in rheumatoid arthritis: Introducing false positive report probability. / Beretta, Lorenzo.

In: Rheumatology, Vol. 48, No. 12, 2009, p. 1619-1620.

Research output: Contribution to journalArticle

@article{12a04bed4eea415b9b10f058e849285f,
title = "Comment on: Methotrexate pharmacogenomics in rheumatoid arthritis: Introducing false positive report probability",
author = "Lorenzo Beretta",
year = "2009",
doi = "10.1093/rheumatology/kep322",
language = "English",
volume = "48",
pages = "1619--1620",
journal = "Rheumatology",
issn = "1462-0324",
publisher = ". Published by Oxford University Press on behalf of the British Society for Rheumatology",
number = "12",

}

TY - JOUR

T1 - Comment on

T2 - Methotrexate pharmacogenomics in rheumatoid arthritis: Introducing false positive report probability

AU - Beretta, Lorenzo

PY - 2009

Y1 - 2009

UR - http://www.scopus.com/inward/record.url?scp=75649152758&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75649152758&partnerID=8YFLogxK

U2 - 10.1093/rheumatology/kep322

DO - 10.1093/rheumatology/kep322

M3 - Article

C2 - 19828599

AN - SCOPUS:75649152758

VL - 48

SP - 1619

EP - 1620

JO - Rheumatology

JF - Rheumatology

SN - 1462-0324

IS - 12

ER -